Richter Gedeon Vegyeszeti Gyar Nyrt banner

Company Overview

Business Description

Sector
Health Care
Industry
Pharmaceuticals
Headquarters
Hungary HU
Employees
11 955
IPO date
Nov 9, 1994

Richter Gedeon is a pharmaceutical company that develops, manufactures, and sells prescription medicines, with a strong focus on treatments for women’s health, central nervous system disorders, and some generic drugs. It also makes active pharmaceutical ingredients and drug products that are used in its own medicines and sold to other drugmakers. Its main customers are hospitals, doctors, pharmacies, health systems, and partner pharma companies in many countries.

The company makes money by selling branded medicines, generic products, and active ingredients, and by licensing or partnering on some of its drug programs. That mix gives it both direct sales and business-to-business revenue. Because drug development is slow and heavily regulated, Richter’s business depends on scientific research, manufacturing quality, and approval processes more than on retail-style selling.

What makes Richter different is its role as both a medicine developer and a manufacturer of pharmaceutical ingredients. That means it is not just packaging products made elsewhere; it sits deeper in the drug supply chain and can profit from multiple steps, from research to production to sale. For investors, it is best thought of as a specialty drug company with a long-established presence in Central and Eastern Europe and a wider international reach.

Richter Gedeon Vegyeszeti Gyar Nyrt Investor Relations

Address
Gyomroi ut 19-21.
Budapest
Hungary

Business Segments

Pharmaceuticals

Richter Gedeon develops, manufactures, and sells branded and generic medicines, including products for women’s health, central nervous system disorders, and other prescription uses. It also makes active ingredients used...

Customers and revenue model

Wholesale and distribution

The company also buys, stores, and distributes medicines in Hungary and nearby markets, linking manufacturers to pharmacies and other healthcare buyers.

Customers and revenue model

Management

Mr. Gabor Orban

CEO, Member of Executive Board & Director

Biography unavailable

Mr. Istvan Hamecz

CFO, Member of Executive Board & Director

Biography unavailable

Dr. Istvan Greiner

R&D Director and Member of Executive Board

Biography unavailable

Ms. Katalin Erdei

HR Director & Member of Executive Board

Biography unavailable

Attila Szenasi

COO & Member of the Executive Board

Biography unavailable

Mr. Tamas Szolyak

Director of Global Regulatory Science and Portfolio Management & Member of Executive Board

Biography unavailable

Mr. Robert Rethy

Head of the Investor Relations & ESG Department

Biography unavailable

1 / 7